Have you successfully transfected cardiomyocytes?
SEARCH ALL SOLUTIONS
If you opened this Solution from a search, your last search results are still available in a separate tab. Click the button below to begin a new search.
Still Have Questions?
If you did not find an answer to your question, please contact us to speak with an expert:
or submit a support request
Yes, we have successfully transfected iCell® Cardiomyocytes and have evaluated several transfection reagents for delivery of plasmid DNA (pDNA), small interfering RNA (siRNA) oligonucleotides, and reporter gene constructs. We routinely observe the highest efficiency, lowest toxicity, and quickest response with ViaFect Transfection Reagent (Promega).
Using a common GFP vector and transfecting with ViaFect reagent, cells showed very high expression at <20 hours as quantified by flow cytometry, low toxicity as determined by CellTiter-Glo Luminescent Cell Viability Assay (Promega), and GFP expression for several weeks.
- Webinar: Build Relevant In Vitro Models Using Human Stem Cell-derived Tissue Cells
- Anson (2015) iPSC-derived Tissue Cells Are a Powerful Addition to the Biologist’s Tool Box
- Application Protocol: Using Liposome-mediated Transfection for Gene Delivery
- Application Note: Applying Transfection Technologies to Create Novel Screen Models